Omnicell Inc. Common Stock ($0.001 par value) (OMCL)
Stock · NASDAQ · Technology
$35.4as of 10/16/2026
Price chart
Active signals
OMCL Signal Track Record
How signals performed across all stocks →What OMCL's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.
| Signal | Times | Median 20-session return | Higher after 20 sessions | Last signal |
|---|---|---|---|---|
| Volume Spike | 36 | -2.9% | 44% | July 21, 2026 |
| Bollinger Band Breakdown | 23 | -4.2% | 26% | July 30, 2026 |
| Bollinger Band Breakout | 19 | +1.5% | 58% | October 6, 2026 |
| 200-Day Moving Average TouchActive now | 4 | +4.2% | 50% | July 23, 2026 |
| Any 20-session window (baseline) | -2.9% | 40% |
Computed by MarketWall from daily closing prices since May 18, 2022. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.
About OMCL
Omnicell, Inc., together with its subsidiaries, provides healthcare technology in the United States and internationally. It offers hospital and health systems solutions, such as points of care for clinician workflows in patient care areas of the healthcare system; Titan XT, an automated dispensing system; XTExtend, a console swap for its XT cabinets; and Central Pharmacy Dispensing Service for the medication dispensi…
- Sector
- Technology
- Industry
- Computer Manufacturing
- Employees
- 3,485
- Website
- www.omnicell.com/
Fundamentals
- 1-day range
- $35.17$36.02
- Market cap
- $1.64B
- P/E (trailing)
- 41.58
- P/E (forward)
- 17.14
- EPS (trailing)
- $0.85
- Dividend yield
- —
- Beta
- 0.92
- Avg. volume
- 670.7K
How Omnicell Inc. Common Stock ($0.001 par value) Makes Money
Where the revenue actually goes — FY2025 annual results
Source: 10-K filed Feb 26, 2026 · via SEC EDGAR / Finnhub
Forecasts
7 analyst ratings
Omnicell Inc. Common Stock ($0.001 par value) Competitors
Chosen by industry and closest market cap.
- OMCLOmnicell Inc. Common Stock ($0.001 par value)$35.39▼ 1.56%Market cap $1.64BP/E 41.58$29.06$55
- OSSOne Stop Systems Inc. Common Stock$5.95▼ 9.16%Market cap $329.92MP/E —$4.17$20.88
- ZEPPZepp Health Corporation American depositary shares each representing sixteen Class A ordinary shares$3.02▼ 5.63%Market cap $68.19MP/E —$3.06$56.28
- SCKTSocket Mobile Inc. Common Stock$0.48▲ 0.00%Market cap $3.21MP/E —$0.38$2.79
- SMCISuper Micro Computer Inc. Common Stock$31.63▼ 9.86%Market cap $17.67BP/E 10.29$19.48$56.6
- HPQHP Inc. Common Stock$30.01▼ 2.72%Market cap $25.77BP/E 11.32$17.56$36.23
- SMCIPSuper Micro Computer Inc. Depositary Shares representing a 1/20th Interest in a Share of 7% Series A Mandatory Convertible Preferred Stock$54.67▼ 8.36%Market cap $31.42BP/E 10.29$19.48$56.6
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| OMCL Omnicell Inc. Common Stock ($0.001 par value) | $1.64B | 41.58 | $35.39 | ▼ 1.56% | $29.06$55 |
| OSS One Stop Systems Inc. Common Stock | $329.92M | — | $5.95 | ▼ 9.16% | $4.17$20.88 |
| ZEPP Zepp Health Corporation American depositary shares each representing sixteen Class A ordinary shares | $68.19M | — | $3.02 | ▼ 5.63% | $3.06$56.28 |
| SCKT Socket Mobile Inc. Common Stock | $3.21M | — | $0.48 | ▲ 0.00% | $0.38$2.79 |
| SMCI Super Micro Computer Inc. Common Stock | $17.67B | 10.29 | $31.63 | ▼ 9.86% | $19.48$56.6 |
| HPQ HP Inc. Common Stock | $25.77B | 11.32 | $30.01 | ▼ 2.72% | $17.56$36.23 |
| SMCIP Super Micro Computer Inc. Depositary Shares representing a 1/20th Interest in a Share of 7% Series A Mandatory Convertible Preferred Stock | $31.42B | 10.29 | $54.67 | ▼ 8.36% | $19.48$56.6 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- Omnicell to Release Third Quarter 2026 Financial Results on October 29, 2026Yahoo · 10/8/2026
- Does Omnicell’s Revenue Beat and Weak EBITDA Guidance Change The Bull Case For OMCL?Yahoo · 10/7/2026
- 1 Healthcare Stock with Exciting Potential and 2 We Find RiskyYahoo · 10/6/2026
- Healthcare Technology for Providers Stocks Q2 Recap: Benchmarking Omnicell (NASDAQ:OMCL)Yahoo · 10/5/2026
- Robotics Earnings Week: Momentum vs. Value as Four Automation Names ReportChartMill · 9/25/2026
- Omnicell (OMCL) Stock Trades Below Fair Value After A 78% SlumpYahoo · 9/22/2026
- 3 Reasons OMCL is Risky and 1 Stock to Buy InsteadYahoo · 9/21/2026
- Strength Seen in Tempus (TEM): Can Its 14.9% Jump Turn into More Strength?Yahoo · 9/18/2026
Insider Activity
Insider Actions →- Njoku Nnamdi · August 17, 2026 · Sale3.1K @ $36.85
- Njoku Nnamdi · August 15, 2026 · Tax Withholding3.7K @ $37.3
- Manley Corey J · August 15, 2026 · Tax Withholding4.0K @ $37.3
- NUTT BRIAN H. · August 15, 2026 · Tax Withholding937 @ $37.3
- LIPPS RANDALL A · August 15, 2026 · Tax Withholding12.3K @ $37.3
- LIPPS RANDALL A · July 15, 2026 · Sale10.0K @ $47
- Njoku Nnamdi · July 1, 2026 · Grant12.3K
- Ghoshal Kaushik · June 1, 2026 · Grant4.6K
- Scott Bruce E · June 1, 2026 · Grant4.6K
- Voynick Eileen J. · June 1, 2026 · Grant4.8K
- Garrett Mary · June 1, 2026 · Grant5.0K
- Edward Peter Bousa · June 1, 2026 · Grant4.6K
- Bauer Joanne B · June 1, 2026 · Grant5.0K
- Seim Robin Gene · June 1, 2026 · Grant4.8K
- Mark W. Parrish · June 1, 2026 · Grant4.8K
Institutional Ownership
March 31, 2026
- Total shares held
- 42.77M
- Total value held
- $1.40B
- Institutional holders
- 264
- Unknown7.21M
- Unknown2.71M
- Unknown2.45M
- Unknown2.29M
- Unknown1.95M
- Unknown1.93M
- Unknown1.47M
- Unknown1.41M
- Unknown1.18M
- Unknown1.14M
See the full, filterable feed with live charts on the MarketWall dashboard.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 14, 2026
Omnicell Set to Release Q3 2026 Results; Guidance Update
Omnicell will publish its third‑quarter 2026 earnings on Oct. 29, 2026. Analysts noted the company beat revenue expectations but issued weaker EBITDA guidance, which may affect the bullish outlook. The stock is currently near its 12‑touch support level of $42.89 and trades below the average analyst target of $57.86.
Omnicell Set to Release Q3 2026 Results; Guidance Update. Omnicell will publish its third‑quarter 2026 earnings on Oct. 29, 2026. Analysts noted the company beat revenue expectations but issued weaker EBITDA guidance, which may affect the bullish outlook. The stock is currently near its 12‑touch support level of $42.89 and trades below the average analyst target of $57.86.